| Name | Title | Contact Details |
|---|
Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company`s focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Approximately 1.7 million Americans have AAA, and the incidence of the condition increases with age. Endologix is currently marketing the AFX® Endovascular AAA System is available in the U.S., Europe, Latin America and other regions. The Nellix® EndoVascular Aneurysm Sealing System, a novel aneurysm sealing system, is approved for sale in Europe and other markets and for investigational use in the U.S. The Powerlink with IntuiTrak® Delivery System is available in Japan. These technologies are minimally invasive, allowing for greater patient comfort and quicker recovery compared to invasive surgical alternatives. Endologix products are protected by at least 52 U.S. patents with at least 956 allowed claims. Endologix is a publicly-held company trading on NASDAQ: ELGX. The Company`s corporate office is located in Irvine, California.
Card Guard AG is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
global choice healthcare is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services.
Ambulatory care at Hotel Dieu Hospital (HDH) is specialized care that may include a scheduled visit to one or more hospital clinics, diagnostic or procedural areas. In some cases, a single health care professional, for example a surgeon or internal medicine physician, may see patients in a traditional clinic setting. Increasingly, patients and families will receive care in a team-based inter-disciplinary and/or inter-professional program, such as our pre-surgical screening, diabetes, breast assessment, bariatric, chronic pain or cardiac rehabilitation programs. Ambulatory care at HDH includes care for patients with urgent and less critical emergency problems at our Urgent Care Centre. Hotel Dieu Hospital has a very active ambulatory surgery program where most patients return home the same day. We also have a short-stay facility in the form of a satellite post-anesthetic care unit that supports patients who need extended time for pain control and rehabilitation therapy. This facility is key to our innovative fast-track total hip and knee arthroplasty program. Hotel Dieu Hospital is a faith-based, academic hospital where research and learning take place every day and where we are committed to partnership with patients and families. We actively engage in implementing innovative models of care that support patient care, as well as regional and academic health care needs. Affiliated with Queen`s University, we serve as a major teaching location for learners from across the Faculty of Health Sciences, including medical, nursing and allied health learners. And research at Hotel Dieu Hospital contributes to the growing field of knowledge about health care and ambulatory care in Canada and beyond. Ambulatory care at Hotel Dieu Hospital is part of an integrated, cost-effective system of health care in Southeastern Ontario.